On August 4, 2016, in the conference hall of Beijing Haoyuan Jianguo Hotel, the "Seventh Northern Region Lymphatic Treatment Center" was jointly organized by the "Peking University Hematology Lymphatic Treatment Center" and the "Clinical Oncology Professional Committee of the Chinese Women Physicians Association". Tumor seminar". More than 200 domestic experts and scholars gathered together to exchange views on the research issues of lymphoma with cellular immunotherapy.
Professor Ke Xiaoyan, Director of the Department of Hematology, Peking University Third Hospital, served as the chairman of this seminar. Professor Ke introduced the development history of the Department of Hematology to the guests and praised the previous seminars on lymphoma. At the meeting, Professor Liu Yong from Shenzhen Yishi Kangning Biotechnology Co., Ltd. shared the literature on the "Preliminary Study of Targeted T Cell Therapy for Diffuse Large B Cell Lymphoma" to the guests. Explained in detail "ACTL targeted cell therapy treatment principle", "ACTL targeted cell therapy preparation process", "ACTL targeted cell therapy safety (no obvious side effects)", "ACTL technology treatment of lymphoma case summary ", "ACTL Targeted Cell Therapy Typical Cases of DLBCL", "ACTL Targeted Cell Therapy Efficacy Judgment Criteria" and other content. It was unanimously recognized by the guest speakers Han Weidong (the pioneer of CART in China), Xiao Lei, Jing Hongmei (deputy director of the Department of Hematology, Peking University Third Hospital) and others. The atmosphere at the meeting was lively and achieved good communication effects.

The successful holding of this seminar has also established a professional exchange and cooperation platform for the development of the oncology discipline and built a bridge of life for more patients.

Warm thanks to the following assisting units:
"Lymph and Hematological Oncology Branch of the Geriatric Oncology Committee of the Chinese Society of Gerontology"
"Lymphoma Professional Committee of Chinese Anti-Cancer Association"
"Northern Lymphoma Collaborative Group"